MedQuest-Inc.com
Title
WorldHeart - Technology for Life
Description
The Novacor II LVAS, currently under development, is a next-generation implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure.
World Heart Corporation (WorldHeart) is a global provider of implantable heart assist devices that deliver pulsatile and rotary blood flow for temporary and long-term support. WorldHeart is committed to providing a better quality of life for our Novacor® Left Ventricular Assist System (LVAS) recipients and maximizing shareholder value by supplying the best products and services in our field. WorldHeart's Novacor® LVAS has unprecedented reliability and durability. It is the first left ventricular assist system to provide a recipient with more than 6 years of circulatory support and continues to hold the industry world record for longest support on a single device, over 4 years.
More than 1,700 patients with life-threatening heart failure have been supported by our leading Novacor® LVAS. Current product development and commercialization focuses on pulsatile and rotary ventricular assist devices (VADs). WorldHeart's Novacor® LVAS, the first and only left ventricular assist device to meet the multi-year Device Readiness Test Protocol of the U.S. National Institutes of Health, is well established in the marketplace with approval for use across the world. WorldHeart is now developing its Rotary VAD and Novacor II LVAS. The Novacor II LVAS is designed to be a miniaturized implantable assist device just half the size of its predecessor, building on the proven Novacor technology and is intended for long-term support of patients with heart failure. In addition, WorldHeart is also in development of a magnetically levitated rotary pump, allowing this company to be the only company to have a product platform of pulsatile and rotary VADs to treat the full spectrum of needs of end-stage and late-stage heart failure patients.
